The CLS-AX program aims to offer flexible dosing using suprachoroidal delivery, which may provide comparable therapeutic effects to current intravitreal treatments while enhancing safety and ...

Photograph of a full-thickness horseshoe retinal tear. Note the small amount of adjacent vitreous hemorrhage. Diagram depicting a single horseshoe retinal tear with a localized superotemporal ...

OCU200 is a recombinant fusion protein targeting integrin receptors with anti-inflammatory and anti-VEGF properties, potentially transforming DME treatment. The phase 1 trial is a multicenter, ...

Myopic complications not only resemble glaucoma but increase the risk of developing it. They also complicate the diagnosis of glaucoma and influence its progression, which represents a challenge for ...